Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1207267

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1207267

Europe Cell Viability Assays Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Application (Stem Cell Research, Drug Discovery & Development, and Diagnostics), By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 128 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Europe Cell Viability Assays Market would witness market growth of 9.0% CAGR during the forecast period (2022-2028).

A commonly measured parameter in the cell viability assays is the integrity of the membrane. Cell-impermeant is membrane integrity dyes that can only enter live cells when there is a compromised plasma membrane. Usually, the membrane integrity viability dyes are made of Nucleic acid binding dyes and amine-reactive dyes.

A nucleic acid binding dye is nonfluorescent in aqueous media but shows increased fluorescence after joining with a double standard DNA or RNA. Propidium iodide (PI), SYTOX dead cell stains, and 7 amino actinomycin D (7 AAD) are some nucleic acid viability dyes. Amine reactive dyes bind covalently with the primary amine group available on the cellular proteins, which are present on the interior and exterior of the cells.

The signal is weak when the amine proteins are attached to the surface but showcases high signal intensity when the dye penetrates the cell with a compromised plasma membrane and reacts with the interior amine cellular protein. For flow cytometry, amine-reactive viability dyes contain live/dead fixable dead cell stains.

The German Federal Ministry of Education and Research (BMBF) published a medical information funding scheme on 16 November 2015 and a corresponding call for proposals, underlining the recognition of digitalization's increasing role in healthcare and the potential to enhance treatment and diagnostics through the adoption of IT in medical research.

The Germany market dominated the Europe Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $160.4 million by 2028. The UK market is anticipated to grow at a CAGR of 8.1% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 9.9% during (2022 - 2028).

Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Consumables
    • Reagents & Assay Kits
  • Luminometric Assays
  • Dye Exclusion Assays
  • Colorimetric Assays
  • Fluorometric Assays
    • Microplates
  • Instruments
    • Spectrophotometer
    • Microscopy
    • Cell Imaging & Analysis System
    • Flow Cytometry
    • Others

By End User

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes
  • Diagnostic Labs

By Application

  • Stem Cell Research
  • Drug Discovery & Development
  • Diagnostics

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • PerkinElmer Inc.
  • Promega Corporation
  • Biotium
  • Creative Bioarray
  • Abcam Plc

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Cell Viability Assays Market, by Product
    • 1.4.2 Europe Cell Viability Assays Market, by End User
    • 1.4.3 Europe Cell Viability Assays Market, by Application
    • 1.4.4 Europe Cell Viability Assays Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and Scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Europe Cell Viability Assays Market by Product

  • 4.1 Europe Consumables Market by Country
  • 4.2 Europe Cell Viability Assays Market by Consumables Type
    • 4.2.1 Europe Reagents & Assay Kits Market by Country
    • 4.2.2 Europe Cell Viability Assays Market by Reagents & Assay Kits Type
      • 4.2.2.1 Europe Luminometric Assays Market by Country
      • 4.2.2.2 Europe Dye Exclusion Assays Market by Country
      • 4.2.2.3 Europe Colorimetric Assays Market by Country
      • 4.2.2.4 Europe Fluorometric Assays Market by Country
    • 4.2.3 Europe Microplates Market by Country
  • 4.3 Europe Instruments Market by Country
  • 4.4 Europe Cell Viability Assays Market by Instruments Type
    • 4.4.1 Europe Spectrophotometer Market by Country
    • 4.4.2 Europe Microscopy Market by Country
    • 4.4.3 Europe Cell Imaging & Analysis System Market by Country
    • 4.4.4 Europe Flow Cytometry Market by Country
    • 4.4.5 Europe Others Market by Country

Chapter 5. Europe Cell Viability Assays Market by End-user

  • 5.1 Europe Biopharmaceutical & Pharmaceutical Companies Market by Country
  • 5.2 Europe CROs & CMOs Market by Country
  • 5.3 Europe Academic & Research Institutes Market by Country
  • 5.4 Europe Diagnostic Labs Market by Country

Chapter 6. Europe Cell Viability Assays Market by Application

  • 6.1 Europe Stem Cell Research Market by Country
  • 6.2 Europe Drug Discovery & Development Market by Country
  • 6.3 Europe Diagnostics Market by Country

Chapter 7. Europe Cell Viability Assays Market by Country

  • 7.1 Germany Cell Viability Assays Market
    • 7.1.1 Germany Cell Viability Assays Market by Product
      • 7.1.1.1 Germany Cell Viability Assays Market by Consumables Type
        • 7.1.1.1.1 Germany Cell Viability Assays Market by Reagents & Assay Kits Type
      • 7.1.1.2 Germany Cell Viability Assays Market by Instruments Type
    • 7.1.2 Germany Cell Viability Assays Market by End-user
    • 7.1.3 Germany Cell Viability Assays Market by Application
  • 7.2 UK Cell Viability Assays Market
    • 7.2.1 UK Cell Viability Assays Market by Product
      • 7.2.1.1 UK Cell Viability Assays Market by Consumables Type
        • 7.2.1.1.1 UK Cell Viability Assays Market by Reagents & Assay Kits Type
      • 7.2.1.2 UK Cell Viability Assays Market by Instruments Type
    • 7.2.2 UK Cell Viability Assays Market by End-user
    • 7.2.3 UK Cell Viability Assays Market by Application
  • 7.3 France Cell Viability Assays Market
    • 7.3.1 France Cell Viability Assays Market by Product
      • 7.3.1.1 France Cell Viability Assays Market by Consumables Type
        • 7.3.1.1.1 France Cell Viability Assays Market by Reagents & Assay Kits Type
      • 7.3.1.2 France Cell Viability Assays Market by Instruments Type
    • 7.3.3 France Cell Viability Assays Market by End-user
    • 7.3.4 France Cell Viability Assays Market by Application
  • 7.4 Russia Cell Viability Assays Market
    • 7.4.1 Russia Cell Viability Assays Market by Product
      • 7.4.1.1 Russia Cell Viability Assays Market by Consumables Type
        • 7.4.1.1.1 Russia Cell Viability Assays Market by Reagents & Assay Kits Type
      • 7.4.1.2 Russia Cell Viability Assays Market by Instruments Type
    • 7.4.2 Russia Cell Viability Assays Market by End-user
    • 7.4.3 Russia Cell Viability Assays Market by Application
  • 7.5 Spain Cell Viability Assays Market
    • 7.5.1 Spain Cell Viability Assays Market by Product
      • 7.5.1.1 Spain Cell Viability Assays Market by Consumables Type
        • 7.5.1.1.1 Spain Cell Viability Assays Market by Reagents & Assay Kits Type
      • 7.5.1.2 Spain Cell Viability Assays Market by Instruments Type
    • 7.5.2 Spain Cell Viability Assays Market by End-user
    • 7.5.3 Spain Cell Viability Assays Market by Application
  • 7.6 Italy Cell Viability Assays Market
    • 7.6.1 Italy Cell Viability Assays Market by Product
      • 7.6.1.1 Italy Cell Viability Assays Market by Consumables Type
        • 7.6.1.1.1 Italy Cell Viability Assays Market by Reagents & Assay Kits Type
      • 7.6.1.2 Italy Cell Viability Assays Market by Instruments Type
    • 7.6.2 Italy Cell Viability Assays Market by End-user
    • 7.6.3 Italy Cell Viability Assays Market by Application
  • 7.7 Rest of Europe Cell Viability Assays Market
    • 7.7.1 Rest of Europe Cell Viability Assays Market by Product
      • 7.7.1.1 Rest of Europe Cell Viability Assays Market by Consumables Type
        • 7.7.1.1.1 Rest of Europe Cell Viability Assays Market by Reagents & Assay Kits Type
      • 7.7.1.2 Rest of Europe Cell Viability Assays Market by Instruments Type
    • 7.7.2 Rest of Europe Cell Viability Assays Market by End-user
    • 7.7.3 Rest of Europe Cell Viability Assays Market by Application

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Product Launches and Product Expansions:
      • 8.1.5.3 Acquisition and Mergers:
      • 8.1.5.4 Geographical Expansions:
  • 8.2 Agilent Technologies, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
  • 8.3 Bio-Rad laboratories, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Acquisition and Mergers:
  • 8.4 Becton, Dickinson and Company
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Product Launches and Product Expansions:
      • 8.4.5.2 Acquisition and Mergers:
  • 8.5 PerkinElmer, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Product Launches and Product Expansions:
      • 8.5.5.2 Acquisition and Mergers:
  • 8.6 Merck KGaA
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
  • 8.7 Abcam plc
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
  • 8.8 Promega Corporation
    • 8.8.1 Company Overview
    • 8.8.2 Recent strategies and developments:
      • 8.8.2.1 Partnerships, Collaborations, and Agreements:
      • 8.8.2.2 Product Launches and Product Expansions:
  • 8.9 Creative Bioarray
    • 8.9.1 Company Overview
  • 8.10. Biotium, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Europe Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Cell Viability Assays Market
  • TABLE 4 Product Launches And Product Expansions- Cell Viability Assays Market
  • TABLE 5 Acquisition and Mergers- Cell Viability Assays Market
  • TABLE 6 Europe Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 7 Europe Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 8 Europe Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 9 Europe Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 10 Europe Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 11 Europe Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 12 Europe Reagents & Assay Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 13 Europe Reagents & Assay Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 14 Europe Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 15 Europe Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 16 Europe Luminometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 17 Europe Luminometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 18 Europe Dye Exclusion Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 19 Europe Dye Exclusion Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 20 Europe Colorimetric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 21 Europe Colorimetric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 22 Europe Fluorometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 23 Europe Fluorometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 24 Europe Microplates Market by Country, 2018 - 2021, USD Million
  • TABLE 25 Europe Microplates Market by Country, 2022 - 2028, USD Million
  • TABLE 26 Europe Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 27 Europe Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 28 Europe Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 29 Europe Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 30 Europe Spectrophotometer Market by Country, 2018 - 2021, USD Million
  • TABLE 31 Europe Spectrophotometer Market by Country, 2022 - 2028, USD Million
  • TABLE 32 Europe Microscopy Market by Country, 2018 - 2021, USD Million
  • TABLE 33 Europe Microscopy Market by Country, 2022 - 2028, USD Million
  • TABLE 34 Europe Cell Imaging & Analysis System Market by Country, 2018 - 2021, USD Million
  • TABLE 35 Europe Cell Imaging & Analysis System Market by Country, 2022 - 2028, USD Million
  • TABLE 36 Europe Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 37 Europe Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 38 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 39 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 40 Europe Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 41 Europe Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 42 Europe Biopharmaceutical & Pharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 43 Europe Biopharmaceutical & Pharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 44 Europe CROs & CMOs Market by Country, 2018 - 2021, USD Million
  • TABLE 45 Europe CROs & CMOs Market by Country, 2022 - 2028, USD Million
  • TABLE 46 Europe Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 47 Europe Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 48 Europe Diagnostic Labs Market by Country, 2018 - 2021, USD Million
  • TABLE 49 Europe Diagnostic Labs Market by Country, 2022 - 2028, USD Million
  • TABLE 50 Europe Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 51 Europe Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 52 Europe Stem Cell Research Market by Country, 2018 - 2021, USD Million
  • TABLE 53 Europe Stem Cell Research Market by Country, 2022 - 2028, USD Million
  • TABLE 54 Europe Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 55 Europe Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 56 Europe Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 57 Europe Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 58 Europe Cell Viability Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 59 Europe Cell Viability Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 60 Germany Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 61 Germany Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 62 Germany Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 63 Germany Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 64 Germany Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 65 Germany Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 66 Germany Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 67 Germany Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 68 Germany Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 69 Germany Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 70 Germany Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 71 Germany Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 72 Germany Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 73 Germany Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 74 UK Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 75 UK Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 76 UK Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 77 UK Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 78 UK Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 79 UK Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 80 UK Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 81 UK Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 82 UK Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 83 UK Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 84 UK Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 85 UK Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 86 UK Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 87 UK Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 88 France Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 89 France Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 90 France Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 91 France Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 92 France Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 93 France Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 94 France Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 95 France Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 96 France Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 97 France Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 98 France Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 99 France Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 100 France Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 101 France Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 102 Russia Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 103 Russia Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 104 Russia Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 105 Russia Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 106 Russia Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 107 Russia Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 108 Russia Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 109 Russia Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 110 Russia Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 111 Russia Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 112 Russia Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 113 Russia Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 114 Russia Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 115 Russia Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 116 Spain Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 117 Spain Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 118 Spain Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 119 Spain Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 120 Spain Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 121 Spain Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 122 Spain Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 123 Spain Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 124 Spain Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 125 Spain Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 126 Spain Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 127 Spain Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 128 Spain Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 129 Spain Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 130 Italy Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 131 Italy Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 132 Italy Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 133 Italy Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 134 Italy Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 135 Italy Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 136 Italy Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 137 Italy Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 138 Italy Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 139 Italy Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 140 Italy Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 141 Italy Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 142 Italy Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 143 Italy Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 144 Rest of Europe Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 145 Rest of Europe Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 146 Rest of Europe Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 147 Rest of Europe Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 148 Rest of Europe Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 149 Rest of Europe Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 150 Rest of Europe Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 151 Rest of Europe Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 152 Rest of Europe Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 153 Rest of Europe Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 154 Rest of Europe Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 155 Rest of Europe Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 156 Rest of Europe Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 157 Rest of Europe Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 158 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 159 key Information - Agilent Technologies, Inc.
  • TABLE 160 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 161 Key information - Becton, Dickinson and Company
  • TABLE 162 key Information - PerkinElmer, Inc.
  • TABLE 163 key Information - Merck KGaA
  • TABLE 164 key information - Abcam plc
  • TABLE 165 key Information - Promega Corporation
  • TABLE 166 Key Information - Creative Bioarray
  • TABLE 167 Key Information - Biotium, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Recent strategies and developments: Thermo Fisher Scientific Inc.
  • FIG 5 Recent strategies and developments: Becton, Dickinson and Company
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!